NAD+ Research Reference: The Coenzyme Behind the “NAD+ Peptide” Search

The NAD+ peptide search term rests on a mix-up: NAD+ (nicotinamide adenine dinucleotide, oxidised form) is not a peptide. It is a dinucleotide coenzyme of about 663.4 g/mol, built from two nucleotides joined through a pyrophosphate bridge, with no amino acids and no peptide bonds. Arthur Harden and William Young first described it in 1906 as the heat-stable “cozymase” fraction of yeast extract, and it is now one of the most measured small molecules in cell biochemistry.

It turns up next to peptides because research suppliers catalogue it as a lyophilised reagent. This article covers its structure, NAD+/NADH redox chemistry, how cultured cells make and move it, how it is measured and how it degrades.

NAD+ at a glance

Source: PubChem compound record 5892; masses calculated from the formulas. Salt forms (for example a sodium salt) have a different formula and molar mass.

Research materials: Vortex supplies NAD+ as a lyophilised research reagent: NAD+ 500mg. Lab reports: /coa/.

Why NAD+ is not a peptide

A peptide is a chain of amino acids joined by amide bonds, read from an N-terminus to a C-terminus. The primer what are peptides sets out that definition. NAD+ has none of those parts. Its two halves are nucleotides, the same family of building blocks as RNA:

• The adenosine half: adenine attached to a ribose, which carries a phosphate on its 5′ carbon.
• The nicotinamide half: nicotinamide attached to a second ribose through a β-glycosidic bond, also carrying a 5′ phosphate. On its own this half is nicotinamide mononucleotide (NMN).
• The bridge: the two phosphates are joined to each other, giving a pyrophosphate (diphosphate) link between the two nucleotides.

The “+” in NAD+ is the positive pyridinium nitrogen of the oxidised nicotinamide ring. The two phosphates are negatively charged at neutral pH, so the whole molecule is an anion in solution; the plus sign names the ring’s oxidation state, not the net charge.

So the analytical questions differ from a peptide’s: not sequence, but ring oxidation state, intact pyrophosphate and glycosidic bonds, and salt form.

NAD+/NADH redox chemistry

NAD+ is a hydride carrier. In a dehydrogenase reaction, the enzyme transfers a hydride ion (a proton plus two electrons) from its substrate to carbon 4 of the nicotinamide ring. The ring loses its aromatic pyridinium character and becomes a 1,4-dihydropyridine, and NAD+ becomes NADH. The reverse reaction hands the hydride back. The pair therefore shuttles electrons between enzymes without being consumed. Trammell and Brenner describe NAD+ as both a coenzyme for hydride-transfer reactions and a substrate for sirtuins and other NAD+-consuming enzymes [2].

The two forms are easy to tell apart by light. The dihydropyridine ring of NADH absorbs strongly near 340 nm and fluoresces, while NAD+ does not absorb there. That single difference underlies most classical enzyme assays and microscopy of cellular NADH. Wolfe and colleagues used the same feature to follow NADH breakdown, because degradation proceeds through oxidation and loss of the dihydropyridine ring and can be tracked by UV-visible absorbance [10].

NADP+ carries an extra phosphate on the 2′ position of the adenosine ribose and forms a separate redox pair. Analytical methods usually measure all four species together [1].

Free versus bound pools

Much of a cell’s NAD+ is bound to proteins at any moment, so total NAD+ and free NAD+ are different numbers. Cambronne and colleagues built a genetically encoded fluorescent biosensor to measure free NAD+ in single subcellular compartments of cultured cells [9]. They reported that free NAD+ concentrations in the nucleus, cytoplasm and mitochondria are close to the Michaelis constants of the sirtuins and PARPs located in each compartment [9].

How cells make NAD+

Cells build NAD+ by several routes that converge on a mononucleotide, which is then joined to AMP.

Source: references 4, 5, 6 and 11; de novo and Preiss-Handler routes as summarised in standard biochemistry texts.

The salvage enzyme Nampt

Revollo, Grimm and Imai measured the kinetics of the two-step salvage route, Nampt followed by NMNAT, and found that Nampt was the rate-limiting component [5]. In mouse fibroblasts, raising Nampt expression, but not NMNAT expression, increased the total cellular NAD level and increased the transcriptional regulatory activity of a Sir2α reporter construct [5]. Wang and colleagues then solved the crystal structure of Nampt with and without its product NMN and showed that it is a dimeric type II phosphoribosyltransferase [11].

Nicotinamide riboside and the NRK enzymes

For decades the accepted view was that NAD+ synthesis in eukaryotes flowed through nicotinic acid mononucleotide. Bieganowski and Brenner showed in 2004 that nicotinamide riboside is an NAD+ precursor in yeast, and identified yeast and human nicotinamide riboside kinases (NRKs) that phosphorylate it with high specificity [4]. They also reported nicotinamide riboside as a component of milk [4].

Where NAD+ sits inside cells

What enters a cultured cell

A practical question for cell work is whether NAD+ added to culture medium enters cells intact. Nikiforov and colleagues addressed this in human cell lines using a mitochondria-targeted PARP activity as a reporter of organelle NAD [6]. They found that nicotinamide, nicotinic acid and the corresponding nucleosides readily entered cells, but nucleotides such as NAD and NMN were broken down outside the cell first, and the cells took up the resulting smaller precursors [6]. All of these precursors could then be converted to cytosolic and mitochondrial NAD.

Mitochondrial NAD+ and the SLC25A51 transporter

The same 2011 study found NMNAT3 in the mitochondrial matrix and proposed that mitochondria make their NAD from NMN taken up from the cytosol [6]. Two papers in 2020 changed that picture. Luongo and colleagues showed that isolated mammalian mitochondria take up intact NAD+, and identified the carrier SLC25A51 (also called MCART1) as a mammalian mitochondrial NAD+ transporter [7]. Loss of SLC25A51 lowered mitochondrial NAD+ but not whole-cell NAD+, and blocked NAD+ uptake into isolated mitochondria. Overexpression of SLC25A51 or its near-identical paralogue SLC25A52 raised mitochondrial NAD+ and restored NAD+ uptake in yeast mitochondria lacking their own transporters [7].

Kory and colleagues reached the same answer by a different route [8]. Mining gene-essentiality data from human cell lines, they found MCART1 to be co-essential with electron transport chain components. MCART1-null cells had large decreases in mitochondrial respiration, complex I activity and mitochondrial NAD+ and NADH. Isolated mitochondria from cells lacking or overexpressing MCART1 showed decreased or increased NAD uptake in vitro, and MCART1 and the yeast transporter NDT1 could substitute for each other [8].

Source: abstracts of references 4 to 9 and 11, checked on PubMed. All are cell, organelle, enzyme or structural studies.

What the NAD+ literature looks like

NAD+ has a literature of a different order from any research peptide: tens of thousands of PubMed records, most of them enzymology, structural biology and cell metabolism. Animal pharmacology and some human studies of NAD+ precursors also exist. This article does not summarise them; its scope is the molecule, its cell-level biochemistry and how a sample is analysed.

How NAD+ is measured

The interconversion problem

The hardest part of measuring NAD+ and NADH in a biological sample is stopping them from turning into each other during extraction. Lu and colleagues compared seven quenching and extraction solvents on cultured mammalian cells and mouse tissue samples, using ¹³C-glucose labelling and spiked unlabelled standards to track interconversion [1]. Interconversion between oxidised and reduced forms was substantial in most solvents. An acidic 40:40:20 acetonitrile:methanol:water mix with 0.1 M formic acid gave the least interconversion and the best analyte return, and the authors advised neutralising extracts straight away to avoid acid-catalysed degradation [1].

LC-MS methods

Trammell and Brenner noted that HPLC with UV-visible detection lacks the specificity and sensitivity needed for complex samples, and developed a targeted LC-MS assay for the NAD+ metabolome that addressed ion suppression for particular compounds [2]. Electrospray ionisation, the soft ionisation method that carries intact polar biomolecules such as nucleotides into the gas phase, is what makes this possible [12].

Redox ratios add a further problem: ionisation efficiency drifts between runs and sample types. Guo and colleagues found in 2026 that the relative signals of oxidised and reduced cofactors change at the same rate across experiments on the same instrument [3]. They expressed that rate as a calibration constant and used it to convert raw signal ratios into NAD+/NADH and NADPH/NADP+ ratios without isotope-labelled internal standards. In their comparison, this approach gave more accurate results than commercial colorimetric kits [3].

A practical detail in the mass spectrum: NAD+ ([M+H]⁺ near m/z 664.12) and NADH (near m/z 666.13) differ by only 2 Da. The natural heavy-isotope peak of NAD+ therefore falls close to the NADH signal, which is one reason chromatographic separation of the two matters even with a mass detector.

Purity of a supplied reagent

For a lyophilised reagent the question is simpler. HPLC-UV purity is the main peak as a share of all detected peak area; likely related substances are breakdown products such as nicotinamide, ADP-ribose, NMN, AMP and NADH. The method and its limits are covered in HPLC purity explained.

Stability of NAD+ and NADH

The oxidised and reduced forms fail in opposite conditions. In standard pyridine-nucleotide chemistry, oxidised NAD+ is relatively stable in mild acid but breaks down in alkaline solution, mainly by cleavage at the nicotinamide-ribose bond. Reduced NADH is the reverse: it is fairly stable in mild alkali but decomposes in acid. Lu and colleagues’ advice to neutralise acidic extracts promptly reflects the acid lability [1].

Buffer choice and temperature matter as well. Wolfe and colleagues followed NAD+ and NADH in sodium phosphate, HEPES and Tris buffers at 19 °C and 25 °C for up to 43 days [10]. Both were highly stable in Tris. NADH in Tris degraded at about 4 µM a day at 19 °C and 11 µM a day at 25 °C, leaving more than 90% and about 75% after 43 days. Degradation was faster in phosphate or HEPES buffer, up to 34 µM a day [10].

Lyophilised NAD+ removes most of the water that drives these reactions, so the solid is far more stable than a solution. It is still hygroscopic, so moisture uptake after the vial is opened is the main risk. General guidance for freeze-dried research materials is in storing lyophilised peptides.

Checking a lot of NAD+

The /coa/ page shows one report for NAD+ 500 mg. It was issued to a wholesale partner facility for batch PS07-NAD500, not commissioned by Vortex, and the page labels it as a partner-facility report. The page states that Vortex stocks the same batch. Testing was done by ILS Laboratories (San Diego, CA), with a test date of 08/12/2026. The report lists:

• Purity (HPLC): 99.45%
• Identity (HPLC): listed; identity by HPLC is a retention-time match against a reference, not a mass measurement
• Net content: 511.02 mg in a vial labelled 500 mg
• Heavy metals (ICP-MS), sterility (PCR), endotoxin (USP <85>), plus a contaminant screen, each listed on the report

The report does not state which salt form was measured, so the molar mass used to convert net content to moles should be confirmed against the supplied material. It also lists no separate NADH assay. The HPLC purity figure covers related substances detected by that method. Each report on the /coa/ page links to the lab’s verification portal. For how these fields are read, see how to read a peptide COA; for the ICP-MS and sterility methods, see sterility and heavy metals testing.

Open questions in NAD+ biochemistry

• How much NAD+ is free? Biosensors measure free NAD+ in compartments [9], while extraction methods measure totals [1]. The two answer different questions.
• How do the pools exchange? SLC25A51 imports intact NAD+ into mitochondria [7, 8], while earlier work showed mitochondrial synthesis from imported NMN [6]. How the two routes share the load in different cell types is still being worked out.

Frequently asked questions

Is NAD+ a peptide?

No. NAD+ is a dinucleotide coenzyme: two nucleotides, one carrying adenine and one carrying nicotinamide, joined by a pyrophosphate bridge. It contains no amino acids and no peptide bonds. It is often listed beside peptides because research suppliers catalogue it as a lyophilised reagent.

What is the difference between NAD+ and NADH?

NAD+ is the oxidised form and NADH is the reduced form. NADH carries an extra hydride on carbon 4 of the nicotinamide ring, which turns the ring into a dihydropyridine. NADH absorbs light near 340 nm and NAD+ does not, which is how most classical assays tell them apart.

Does NAD+ enter cultured cells intact?

In human cell lines, Nikiforov and colleagues found that extracellular NAD and NMN were broken down outside the cell, and the cells took up smaller precursors such as nicotinamide and the nucleosides. Isolated mitochondria, by contrast, import intact NAD+ through the SLC25A51 transporter.

What does the NAD+ lab report on the Vortex site show?

The report for batch PS07-NAD500 is a partner-facility report from ILS Laboratories, tested 08/12/2026. It lists 99.45% purity by HPLC, identity by HPLC, net content of 511.02 mg, and heavy metals, sterility, endotoxin and contaminant screens. The full report is on the /coa/ page.

About this article: Written by the Vortex Research Editorial Team. Sources were chosen from peer-reviewed papers indexed in PubMed, with priority given to enzymology, cell-biology and analytical studies that state their model and measurement. Each PMID was checked against PubMed for title, journal and year, and each sentence was matched to the paper’s abstract. Identity data come from PubChem, quoted without linking.

Research materials: NAD+ 500mg is supplied as a lyophilised research reagent. Published lab reports are at /coa/.

References

1. Lu W, Wang L, Chen L, Hui S, Rabinowitz JD. Extraction and quantitation of nicotinamide adenine dinucleotide redox cofactors. Antioxid Redox Signal. 2018;28(3):167-179. PMID: 28497978. doi:10.1089/ars.2017.7014
2. Trammell SA, Brenner C. Targeted, LCMS-based metabolomics for quantitative measurement of NAD(+) metabolites. Comput Struct Biotechnol J. 2013;4:e201301012. PMID: 24688693. doi:10.5936/csbj.201301012
3. Guo Q, Wang ML, Schwaiger-Haber M, et al. Rapid quantitation of NAD(+)/NADH and NADPH/NADP(+) with mass spectrometry by using calibration constants. Redox Biol. 2026;89:103953. PMID: 41389769. doi:10.1016/j.redox.2025.103953
4. Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell. 2004;117(4):495-502. PMID: 15137942. doi:10.1016/s0092-8674(04)00416-7
5. Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004;279(49):50754-50763. PMID: 15381699. doi:10.1074/jbc.M408388200
6. Nikiforov A, Dölle C, Niere M, Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem. 2011;286(24):21767-21778. PMID: 21504897. doi:10.1074/jbc.M110.213298
7. Luongo TS, Eller JM, Lu MJ, et al. SLC25A51 is a mammalian mitochondrial NAD(+) transporter. Nature. 2020;588(7836):174-179. PMID: 32906142. doi:10.1038/s41586-020-2741-7
8. Kory N, Uit de Bos J, van der Rijt S, et al. MCART1/SLC25A51 is required for mitochondrial NAD transport. Sci Adv. 2020;6(43):eabe5310. PMID: 33087354. doi:10.1126/sciadv.abe5310
9. Cambronne XA, Stewart ML, Kim D, et al. Biosensor reveals multiple sources for mitochondrial NAD⁺. Science. 2016;352(6292):1474-1477. PMID: 27313049. doi:10.1126/science.aad5168
10. Wolfe KD, Alahuhta M, Himmel ME, Bomble YJ, Jennings GK, Cliffel DE. Long-term stability of nicotinamide cofactors in common aqueous buffers: implications for cell-free biocatalysis. Molecules. 2024;29(22):5453. PMID: 39598842. doi:10.3390/molecules29225453
11. Wang T, Zhang X, Bheda P, Revollo JR, Imai S, Wolberger C. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat Struct Mol Biol. 2006;13(7):661-662. PMID: 16783373. doi:10.1038/nsmb1114
12. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. PMID: 2675315. doi:10.1126/science.2675315

Vortex Research products are sold for in-vitro laboratory research by qualified researchers. Not for human or veterinary use. Not a drug, dietary supplement or cosmetic. Statements have not been evaluated by the FDA.